Uscom Limited (UCM.AX)
AUD 0.03
(19.05%)
AUD 0.03
(19.05%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 989.27 Thousand AUD | -9.37% |
| 2023 | 1.09 Million AUD | -16.8% |
| 2022 | 1.31 Million AUD | -8.24% |
| 2021 | 1.42 Million AUD | -11.58% |
| 2020 | 1.61 Million AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 4350.00 AUD | -66.67% |
| 2007 | 13.05 Thousand AUD | 101.75% |
| 2006 | 6469.00 AUD | -66.67% |
| 2005 | 19.4 Thousand AUD | 0.0% |
| 2003 | 4715.00 AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.04 Million AUD | 0.0% |
| 2024 FY | 989.27 Thousand AUD | -9.37% |
| 2024 Q4 | 989.27 Thousand AUD | 0.0% |
| 2023 Q2 | 1.14 Million AUD | 0.0% |
| 2023 Q4 | 1.09 Million AUD | 0.0% |
| 2023 FY | 1.09 Million AUD | -16.8% |
| 2022 FY | 1.31 Million AUD | -8.24% |
| 2022 Q2 | 1.37 Million AUD | 0.0% |
| 2022 Q4 | 1.31 Million AUD | 0.0% |
| 2021 FY | 1.42 Million AUD | -11.58% |
| 2021 Q4 | 1.42 Million AUD | 0.0% |
| 2021 Q2 | 1.51 Million AUD | 0.0% |
| 2020 Q4 | 1.61 Million AUD | 0.0% |
| 2020 FY | 1.61 Million AUD | 0.0% |
| 2020 Q2 | 1.59 Million AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | 4350.00 AUD | -66.67% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 FY | 13.05 Thousand AUD | 101.75% |
| 2007 Q4 | 13.05 Thousand AUD | 0.0% |
| 2006 FY | 6469.00 AUD | -66.67% |
| 2006 Q4 | 6469.00 AUD | 0.0% |
| 2005 Q4 | 19.4 Thousand AUD | 0.0% |
| 2005 FY | 19.4 Thousand AUD | 0.0% |
| 2003 FY | 4715.00 AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 80.68% |
| Adherium Limited | 93.2 Thousand AUD | -961.4% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 85.488% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -1068.393% |
| Anteris Technologies Ltd | 2.33 Million AUD | 57.595% |
| Control Bionics Limited | 961.73 Thousand AUD | -2.864% |
| CardieX Limited | 3.22 Million AUD | 69.351% |
| Compumedics Limited | 6.97 Million AUD | 85.821% |
| Cochlear Limited | 243.7 Million AUD | 99.594% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 71.294% |
| Cyclopharm Limited | 4.22 Million AUD | 76.598% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 65.891% |
| Nova Eye Medical Limited | 3.34 Million AUD | 70.46% |
| HeraMED Limited | 260.65 Thousand AUD | -279.534% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 93.699% |
| ImpediMed Limited | 1.14 Million AUD | 13.449% |
| InhaleRx Limited | 560.27 Thousand AUD | -76.57% |
| LBT Innovations Limited | 1.74 Million AUD | 43.243% |
| Micro-X Limited | 4.05 Million AUD | 75.603% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -1299.816% |
| PolyNovo Limited | 15.38 Million AUD | 93.568% |
| Respiri Limited | 1.17 Million AUD | 15.918% |
| SomnoMed Limited | 1.01 Million AUD | 2.631% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 80.101% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -216.918% |